Zhuhai Rundu Pharmaceutical Co., Ltd.

Form 483 issued September 20, 2019 · Zhuhai City, China

Observations
2
Pages
1
FEI number
3009954717

In short: On September 20, 2019, FDA issued a Form 483 with 2 observations to Zhuhai Rundu Pharmaceutical Co., Ltd. in Zhuhai City, Guangdong (FEI 3009954717). The investigator was Jeffrey P. Raimondi. Most observations concern quality system and facilities & equipment; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Quality system and facilities & equipment account for 2 of 2 observations.

Quality system1
Facilities & equipment1

Most cited: 21 CFR 211.192 (1×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Investigations into complaints are…

  2. 02

    Schedules and procedures have not been established for the…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Zhuhai Rundu Pharmaceutical Co., Ltd.?

FDA listed 2 observations on this Form 483, mostly about quality system and facilities & equipment. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Zhuhai Rundu Pharmaceutical Co., Ltd.?

Jeffrey P. Raimondi is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Zhuhai Rundu Pharmaceutical Co., Ltd. inspected by FDA?

This Form 483 is dated September 20, 2019.

How do I get the full Form 483 for Zhuhai Rundu Pharmaceutical Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free